|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nieder C, Mehta MP and Jalali R: Combined
radio- and chemotherapy of brain tumours in adult patients. Clin
Oncol (R Coll Radiol). 21:515–524. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fidoamore A, Cristiano L, Antonosante A,
d'Angelo M, Di Giacomo E, Astarita C, Giordano A, Ippoliti R,
Benedetti E and Cimini A: Glioblastoma stem cells microenvironment:
The paracrine roles of the niche in drug and radioresistance. Stem
Cells Int. 2016:68091052016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Argyriou AA and Kalofonos HP: Molecularly
targeted therapies for malignant gliomas. Mol Med. 15:115–122.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kasibhatla S and Tseng B: Why target
apoptosis in cancer treatment? Mol Cancer Therap. 2:573–580.
2003.
|
|
7
|
Wong ML, Kaye AH and Hovens CM: Targeting
malignant glioma survival signalling to improve clinical outcomes.
J Clin Neurosci. 14:301–308. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun SY, Hail N Jr and Lotan R: Apoptosis
as a novel target for cancer chemoprevention. J Natl Cancer Inst.
96:662–672. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Biswas DK, Shi Q, Baily S, Strickland I,
Ghosh S, Pardee AB and Iglehart JD: NF-kappa B activation in human
breast cancer specimens and its role in cell proliferation and
apoptosis. Proc Natl Acad Sci USA. 101:10137–10142. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen HM and Tergaonkar V: NFkappaB
signaling in carcinogenesis and as a potential molecular target for
cancer therapy. Apoptosis. 14:348–363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guan H, Zhang H, Cai J, Wu J, Yuan J, Li
J, Huang Z and Li M: IKBKE is over-expressed in glioma and
contributes to resistance of glioma cells to apoptosis via
activating NF-κB. J Pathol. 223:436–445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kumar DM, Patil V, Ramachandran B, Nila
MV, Dharmalingam K and Somasundaram K: Temozolomide-modulated
glioma proteome: Role of interleukin-1 receptor-associated kinase-4
(IRAK4) in chemosensitivity. Proteomics. 13:2113–2124. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamagishi N, Miyakoshi J and Takebe H:
Enhanced radiosensitivity by inhibition of nuclear factor kappa B
activation in human malignant glioma cells. Int J Radiat Biol.
72:157–162. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Angileri FF, Aguennouz M, Conti A, La
Torre D, Cardali S, Crupi R, Tomasello C, Germanò A, Vita G and
Tomasello F: Nuclear factor-kappaB activation and differential
expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
Cancer. 112:2258–2266. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wong ET and Tergaonkar V: Roles of
NF-kappaB in health and disease: Mechanisms and therapeutic
potential. Clin Sci (Lond). 116:451–465. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sizemore N, Lerner N, Dombrowski N,
Sakurai H and Stark GR: Distinct roles of the Ikappa B kinase alpha
and beta subunits in liberating nuclear factor kappa B (NF-kappa B)
from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B.
J Biol Chem. 277:3863–3869. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mankan AK, Lawless MW, Gray SG, Kelleher D
and McManus R: NF-kappaB regulation: The nuclear response. J Cell
Mol Med. 13:631–643. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Antoon JW, White MD, Slaughter EM, Driver
JL, Khalili HS, Elliott S, Smith CD, Burow ME and Beckman BS:
Targeting NFκB mediated breast cancer chemoresistance through
selective inhibition of sphingosine kinase-2. Cancer Biol Ther.
11:678–689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Santini D, Schiavon G, Vincenzi B, Gaeta
L, Pantano F, Russo A, Ortega C, Porta C, Galluzzo S, Armento G, et
al: Receptor activator of NF-kB (RANK) expression in primary tumors
associates with bone metastasis occurrence in breast cancer
patients. PLoS One. 6:e192342011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hoshiya Y, Gupta V, Segev DL, Hoshiya M,
Carey JL, Sasur LM, Tran TT, Ha TU and Maheswaran S: Mullerian
inhibiting substance induces NFkB signaling in breast and prostate
cancer cells. Mol Cell Endocrinol. 211:43–49. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mani A and Gelmann EP: The
ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol.
23:4776–4789. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rajan N, Elliott RJ, Smith A, Sinclair N,
Swift S, Lord CJ and Ashworth A: The cylindromatosis gene product,
CYLD, interacts with MIB2 to regulate notch signalling. Oncotarget.
5:12126–12140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vigneswaran K, Neill S and Hadjipanayis
CG: Beyond the world health organization grading of infiltrating
gliomas: Advances in the molecular genetics of glioma
classification. Ann Transl Med. 3:952015.PubMed/NCBI
|
|
24
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nature Protoc.
3:1101–1108. 2008. View Article : Google Scholar
|
|
25
|
Kämmerer U, Kapp M, Gassel AM, Richter T,
Tank C, Dietl J and Ruck P: A new rapid immunohistochemical
staining technique using the EnVision antibody complex. J Histochem
Cytochem. 49:623–630. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bednarski BK, Ding X, Coombe K, Baldwin AS
and Kim HJ: Active roles for inhibitory kappaB kinases alpha and
beta in nuclear factor-kappaB-mediated chemoresistance to
doxorubicin. Mol Cancer Therap. 7:1827–1835. 2008. View Article : Google Scholar
|
|
27
|
McClelland RA, Finlay P, Walker KJ,
Nicholson D, Robertson JF, Blamey RW and Nicholson RI: Automated
quantitation of immunocytochemically localized estrogen receptors
in human breast cancer. Cancer Res. 50:3545–3550. 1990.PubMed/NCBI
|
|
28
|
Jung Y, Joo KM, Seong DH, Choi YL, Kong
DS, Kim Y, Kim MH, Jin J, Suh YL, Seol HJ, et al: Identification of
prognostic biomarkers for glioblastomas using protein expression
profiling. Int J Oncol. 40:1122–1132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pitlick FA: Binding of bovine brain tissue
factor to concanavalin A-Sepharose. Partial purification of
coagulant, arylamidase, and alkaline phosphatase activities.
Biochim Biophys Acta. 428:27–34. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tu Y, Chen C, Pan J, Xu J, Zhou ZG and
Wang CY: The ubiquitin proteasome pathway (UPP) in the regulation
of cell cycle control and DNA damage repair and its implication in
tumorigenesis. Int J Clin Exp Pathol. 5:726–738. 2012.PubMed/NCBI
|
|
31
|
Wang X and Michaelis EK: Selective
neuronal vulnerability to oxidative stress in the brain. Front
Aging Neurosci. 2:122010.PubMed/NCBI
|
|
32
|
Koo BK, Yoon KJ, Yoo KW, Lim HS, Song R,
So JH, Kim CH and Kong YY: Mind bomb-2 is an E3 ligase for Notch
ligand. J Biol Chem. 280:22335–22342. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koo BK, Yoon MJ, Yoon KJ, Im SK, Kim YY,
Kim CH, Suh PG, Jan YN and Kong YY: An obligatory role of mind
bomb-1 in notch signaling of mammalian development. PLoS One.
2:e12212007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ye JS, Kim N, Lee KJ, Nam YR, Lee U and
Joo CH: Lysine 63-linked TANK-binding kinase 1 ubiquitination by
mindbomb E3 ubiquitin protein ligase 2 is mediated by the
mitochondrial antiviral signaling protein. J Virol. 88:12765–12776.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Takeuchi T, Heng HH, Ye CJ, Liang SB,
Iwata J, Sonobe H and Ohtsuki Y: Down-regulation of a novel
actin-binding molecule, skeletrophin, in malignant melanoma. Am J
Pathol. 163:1395–1404. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nguyen HT, Voza F, Ezzeddine N and Frasch
M: Drosophila mind bomb2 is required for maintaining muscle
integrity and survival. J Cell Biol. 179:219–227. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Barsi JC, Rajendra R, Wu JI and Artzt K:
Mind bomb1 is a ubiquitin ligase essential for mouse embryonic
development and Notch signaling. Mech Dev. 122:1106–1117. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Q, Wang X and Evers BM: Induction of
cIAP-2 in human colon cancer cells through PKC delta/NF-kappa B. J
Biol Chem. 278:51091–51099. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hinz M, Loser P, Mathas S, Krappmann D,
Dörken B and Scheidereit C: Constitutive NF-kappaB maintains high
expression of a characteristic gene network, including CD40, CD86,
and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.
Blood. 97:2798–2807. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Baldwin AS: Control of oncogenesis and
cancer therapy resistance by the transcription factor NF-kappaB. J
Clin Invest. 107:241–246. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nakshatri H, Bhat-Nakshatri P, Martin DA,
Goulet RJ Jr and Sledge GW Jr: Constitutive activation of NF-kappaB
during progression of breast cancer to hormone-independent growth.
Mol Cell Biol. 17:3629–3639. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cusack JC, Liu R and Baldwin AS: NF- kappa
B and chemoresistance: Potentiation of cancer drugs via inhibition
of NF-kappa B. Drug Resist Updat. 2:271–273. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cusack JC Jr, Liu R, Houston M, Abendroth
K, Elliott PJ, Adams J and Baldwin AS Jr: Enhanced chemosensitivity
to CPT-11 with proteasome inhibitor PS-341: Implications for
systemic nuclear factor-kappaB inhibition. Cancer Res.
61:3535–3540. 2001.PubMed/NCBI
|
|
44
|
Lu TP, Lai LC, Lin BI, Chen LH, Hsiao TH,
Liber HL, Cook JA, Mitchell JB, Tsai MH and Chuang EY: Distinct
signaling pathways after higher or lower doses of radiation in
three closely related human lymphoblast cell lines. Int J Radiat
Oncol Biol Phys. 76:212–219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Roos WP, Batista LF, Naumann SC, Wick W,
Weller M, Menck CF and Kaina B: Apoptosis in malignant glioma cells
triggered by the temozolomide-induced DNA lesion O6-methylguanine.
Oncogene. 26:186–197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Alberts SR, Foster NR, Morton RF, Kugler
J, Schaefer P, Wiesenfeld M, Fitch TR, Steen P, Kim GP and Gill S:
PS-341 and gemcitabine in patients with metastatic pancreatic
adenocarcinoma: A north central cancer treatment group (NCCTG)
randomized phase II study. Ann Oncol. 16:1654–1661. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ali F and Sultana S: Repeated short-term
stress synergizes the ROS signalling through up regulation of NFkB
and iNOS expression induced due to combined exposure of
trichloroethylene and UVB rays. Mol Cell Biochem. 360:133–145.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Triscott J, Rose Pambid M and Dunn SE:
Concise review: Bullseye: Targeting cancer stem cells to improve
the treatment of gliomas by repurposing disulfiram. Stem cells.
33:1042–1046. 2015. View Article : Google Scholar : PubMed/NCBI
|
